Total raised
—
Stage
Mature
Founded
2011
Headcount
3
HQ
Jerusalem
Sector
Health Tech & Life Sciences
About
Genefron develops and produces personal genomic diagnostic kits. The company uses gene expression signatures derived from bioinformatic developments to provide in-vitro companion diagnostics. Genefron has fully developed diagnostic kits (CE marked and Israeli OTC) for viral and autoimmune diseases and therapies including rheumatoid arthritis, multiple sclerosis, and cytomegalovirus.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Genefron's primary business?
- Genefron develops and produces personal genomic diagnostic kits, utilizing gene expression signatures from bioinformatic developments to provide in-vitro companion diagnostics.
- When was Genefron founded?
- Genefron was founded in January 2011.
- What is Genefron's current operational status?
- Genefron is currently inactive and ceased to operate in August 2024.
- Where is Genefron headquartered?
- Genefron is headquartered in Jerusalem, Israel, at Hartom Street 19.
- What types of diagnostic kits has Genefron developed?
- Genefron has developed CE marked and Israeli OTC diagnostic kits for viral and autoimmune diseases and therapies, including rheumatoid arthritis, multiple sclerosis, and cytomegalovirus.
- How many employees does Genefron have?
- Genefron has 3 employees.
- Who is a founder of Genefron?
- Yaniv Kotler is a founder of Genefron.
- What are some of Genefron's developed products?
- Genefron's developed products include IFR 300 In RA, IFR 100 In MS, and IFR 200.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportDigital Medical Diagnostics
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesConsumersDemographics & FamilyWomen
Business model
B2B
Highlights
1 PatentsVerified
Tags
viral-diseasesmedical-technologiesbioinformaticsdiagnosticsgeneticsbiomarkersgenomicspregnancymultiple-sclerosischronic-patientslaboratorieswomenpersonalized-medicine